Cavilon Breast Trial: Comparison of Cavilon Durable Barrier Cream to Glycerine ("Sorbolene") Cream
Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
This study has patients using two different moisturising creams during radiation therapy
after mastectomy. These are Cavilon and sorbolene. It is hypothesised that skin reactions may
be reduced by the Cavilon cream compared to sorbolene.
Phase:
Phase 3
Details
Lead Sponsor:
Trans Tasman Radiation Oncology Group Trans-Tasman Radiation Oncology Group (TROG)